High-dose chemotherapy for ovarian carcinoma: Long-term results from the solid tumour registry of the European group for blood and marrow transplantation (EBMT)

Annals of Oncology

Volumn 12, Issue 5, 2001, Pages 693-699

  Ledermann, J A ^a   Herd, R ^a   Maraninchi, D ^b   Viens, P ^b   Buclon, M ^c   Philip, T ^c   Cure, H ^d   Lotz, J P ^e   Chauvin, F ^c   Ferrante, P ^f   Rosti, G ^f  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b INSTITUT PAOLI CALMETTES   (France)

^c CENTRE LÉON BÉRARD   (France)

^d CENTRE JEAN PERRIN   (France)

^e HÔPITAL TENON   (France)

^f Ospedale Civile   (Italy)

Author keywords

Bone marrow transplantation; High dose chemotherapy; Ovarian cancer; Ovary cancer; Peripheral blood stem cell transplantation

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; MELPHALAN;

ADOLESCENT; ADULT; ADVANCED CANCER; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER RECURRENCE; CANCER REGISTRY; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DRUG MEGADOSE; DRUG RESPONSE; EUROPE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OVARY CANCER; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 0034991322     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011136807190     Document Type: Article

References (24)

1. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer
2. Randomized intergroup trial of cisplatin paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: Three-year results
3. Long term survival in ovarian cancer: Mature data from The Netherlands Joint Study Group for Ovarian Cancer
4. Chemotherapy in advanced ovarian cancer: An overview of randomised clinical trials
5. Dose intensity analysis of chemotherapy regimens in ovarian carcinoma
6. Importance of multiagent chemotherapy regimens in ovarian carcinoma: Dose intensity analysis
7. Dose-intensity in ovarian carcinoma. Hold, enough?
8. High-dose chemotherapy with autologous bone marrow support for the treatment of epithelial ovarian cancer
9. High dose melphalan and autologous marrow rescue in advanced epithelial ovarian carcinomas: A retrospective analysis of 35 patients treated in France
10. Phase I-II study of two consecutive courses of high-dose epipodophyllotoxin, ifosfamide, and carboplatin with autologous bone marrow transplantation for treatment of adult patients with solid tumors
11. High-dose chemotherapy with autologous peripheral stem cell support in advanced ovarian cancer
12. A phase II trial of high-dose mitoxantrone, carboplatin, and cyclophosphamide with autologous bone marrow rescue for recurrent epithelial ovarian carcinoma: Analysis of risk factors for clinical outcome
13. High-dose chemotherapy with hematopoietic rescue in patients with stage III to IV ovarian cancer: Long-term results
14. Dose escalation of paclitaxel with high-dose cyclophosphamide, with analysis of progenitor-cell mobilization and hematologic support of advanced ovarian cancer patients receiving rapidly sequenced high-dose cyclophosphamide courses
15. High-dose chemotherapy with autologous transplantation for persistent/relapsed ovarian cancer: A multivariate analysis of survival for 100 consecutively treated patients
16. Prognostic factors in advanced epithelial ovarian cancer
17. How many more nails to seal the coffin of dose intensity?
18. Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancer
19. A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow support
20. Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: A feasibility study
21. High dose chemotherapy in ovarian cancer: An analysis of the experience of the European Group for Blood and Marrow Transplant (EBMT) over 7 years
22. High-dose chemotherapy and autologous stem-cell transplantation for ovarian cancer: An autologous blood and marrow transplant registry report
23. Sequential cycles of high-dose chemotherapy with dose escalation of carboplatin with or without paclitaxel supported by G-CSF mobilized peripheral blood progenitor cells: A phase I/II study in advanced ovarian cancer
24. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: Current practice in Europe in 1998